[HTML][HTML] Microbiota alterations in proline metabolism impact depression
J Mayneris-Perxachs, A Castells-Nobau… - Cell metabolism, 2022 - cell.com
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
Microbiota alterations in proline metabolism impact depression.
J Mayneris-Perxachs, A Castells-Nobau… - Cell …, 2022 - europepmc.org
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
[PDF][PDF] Microbiota alterations in proline metabolism impact depression
L de la Vega-Correa, C Zapata, A Burokas, G Blasco… - Cell Metabolism, 2022 - core.ac.uk
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
Microbiota alterations in proline metabolism impact depression
J Mayneris-Perxachs, A Castells-Nobau… - 2022 - digital.csic.es
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
[PDF][PDF] Microbiota alterations in proline metabolism impact depression
L de la Vega-Correa, C Zapata, A Burokas… - Cell …, 2022 - researchgate.net
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
Microbiota alterations in proline metabolism impact depression
J Mayneris-Perxachs, A Castells-Nobau… - Cell …, 2022 - pure.mpg.de
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
Microbiota alterations in proline metabolism impact depression
J Mayneris-Perxachs, A Castells-Nobau… - Cell …, 2022 - epublications.vu.lt
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
Microbiota alterations in proline metabolism impact depression
J Mayneris-Perxachs, A Castells-Nobau… - Cell …, 2022 - pubmed.ncbi.nlm.nih.gov
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
Microbiota alterations in proline metabolism impact depression
J Mayneris Perxachs, A Castells Nobau… - … , 2022, vol. 34, núm …, 2022 - dugi-doc.udg.edu
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
[HTML][HTML] Microbiota alterations in proline metabolism impact depression
J Mayneris-Perxachs, A Castells-Nobau… - Cell Metabolism, 2022 - cell.com
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with
low treatment efficacy. However, the field is dominated by underpowered studies focusing …
low treatment efficacy. However, the field is dominated by underpowered studies focusing …